What's new

Human medicines European public assessment report (EPAR): Xenpozyme, olipudase alfa, Date of authorisation: 24/06/2022, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Xenpozyme, olipudase alfa, Date of authorisation: 24/06/2022, Revision: 6, Status: Authorised

Mar 26, 2025 - 15:45
 0
Human medicines European public assessment report (EPAR): Xenpozyme, olipudase alfa, Date of authorisation: 24/06/2022, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Xenpozyme, olipudase alfa, Date of authorisation: 24/06/2022, Revision: 6, Status: Authorised
Read More

Tags:

Previous Article

Dollar Tree says it's winning over higher-income shoppers and may offset tariffs...

Next Article

Ratepayer advocates urge FERC to reject proposed Constellation-Calpine deal

Related Posts

Minutes of the CAT meeting 4-6 December 2024

Mar 24, 2025  0

Human medicines European public assessment report (EPAR): Xaluprine (previously Mercaptopurine Nova Laboratories), mercaptopurine, Date of authorisation: 09/03/2012, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 13, 2025  0

Clinical Trials Information System (CTIS) bitesize talk: Change of sponsor in CTIS, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 5 March 2025, 15:30 (CET) to 5 March 2025, 17:00 (CET)

Clinical Trials Information System (CTIS) bitesize talk...

Feb 9, 2025  0